NCCN guidelines insights: Hodgkin lymphoma, version 1.2018: Featured updates to the NCCN guidelines Journal Article

  


Authors: Hoppe, R. T.; Advani, R. H.; Ai, W. Z.; Ambinder, R. F.; Aoun, P.; Armand, P.; Bello, C. M.; Benitez, C. M.; Bierman, P. J.; Chen, R.; Dabaja, B.; Dean, R.; Forero, A.; Gordon, L. I.; Hernandez-Ilizaliturri, F. J.; Hochberg, E. P.; Huang, J.; Johnston, P. B.; Kaminski, M. S.; Kenkre, V. P.; Khan, N.; Maddocks, K.; Maloney, D. G.; Metzger, M.; Moore, J. O.; Morgan, D.; Moskowitz, C. H.; Mulroney, C.; Rabinovitch, R.; Seropian, S.; Tao, R.; Winter, J. N.; Yahalom, J.; Burns, J. L.; Ogba, N.
Article Title: NCCN guidelines insights: Hodgkin lymphoma, version 1.2018: Featured updates to the NCCN guidelines
Abstract: The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN Guidelines Panel meets at least annually to review comments from reviewers within the NCCN Member Institutions, examine relevant data, and reevaluate and update the recommendations. These NCCN Guidelines Insights summarize recent updates centered on treatment considerations for relapsed/refractory classic HL. © National Comprehensive Cancer Network, Inc. 2018, All rights reserved.
Keywords: unclassified drug; systemic therapy; cancer radiotherapy; drug megadose; antineoplastic agent; practice guideline; hodgkin disease; allogeneic hematopoietic stem cell transplantation; accreditation; continuing education; protein inhibitor; polyacrylamide gel electrophoresis; classical hodgkin lymphoma; brentuximab vedotin; human; article; programmed death 1 receptor inhibitor
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 16
Issue: 3
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2018-03-01
Start Page: 245
End Page: 254
Language: English
DOI: 10.6004/jnccn.2018.0013
PROVIDER: scopus
PUBMED: 29523663
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044038568&doi=10.6004%2fjnccn.2018.0013&partnerID=40&md5=2b313c6b4980317c6f06ba7826d00a81
Notes: Publisher-provided DOI does not resolve (as of 7/24/2018) -- Article -- Export Date: 2 April 2018 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Joachim Yahalom
    625 Yahalom
  2. Craig Moskowitz
    407 Moskowitz
Related MSK Work